Sub-anesthetic and anesthetic ketamine produce different long-lasting behavioral phenotypes (24 h post-treatment) via inducing different brain-derived neurotrophic factor (BDNF) expression level in the hippocampus
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Clinical and preclinical researches have shown that sub-anesthetic ketamine elicits sustained antidepressant effects for up to 1-2 weeks. Pharmacokinetics studies (t1/2 = 23 min) in mice showed no ketamine residue at 24 h after sub-anesthetic or anesthetic ketamine administration. Therefore, this study aims to reveal the mechanism underlying these different biological functions at 24 h after sub-anesthetic and anesthetic ketamine treatment. First, at the animal behavioral level, we found that sub-anesthetic ketamine induced antidepressant and anxiolytic effects while anesthetic ketamine induced depressive-like phenotypes and cognitive impairment. Second, we examined the correlation between behavior phenotype and protein expression, and found that the Brain-derived neurotrophic factor (BDNF) level is oppositely regulated by sub-anesthetic and anesthetic ketamine. Sub-anesthetic ketamine significantly increased the BDNF level, correlating to antidepressant effects; whereas anesthetic dose reduced BDNF expression in the hippocampus, correlating to depressive-like behaviors, anxiety-like behaviors and cognitive impairment. Third, the antidepressant effects of sub-anesthetic ketamine were prevented by pre-treatment of ANA-12, a Tropomyosin receptor kinase B (TrkB) inhibitor. Thus, we conclude that BDNF may be the key factor underlying antidepressant and anxiolytic effects of sub-anesthetic ketamine at 24 h after treatment. These results may shed light on future studies and the development of long-lasting anti-depressant drugs and therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Ketamine—its pharmacology and therapeutic uses
white, P. F., Way, W. L., & Trevor, A. J. (1982) · Anesthesiology · doi:10.1097/00000542-198202000-00007 · Cited by 1,474
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030392 · Cited by 1,205
Murrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786
Regulatory mechanisms of AMPA receptors in synaptic plasticity
Derkach, V. A., Oh, M. C., Guire, E. S., & Soderling, T. R. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2055 · Cited by 708
Zhou, W., Wang, N., Yang, C., Li, X.-M., Zhou, Z.-Q., & Yang, J.-J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.10.005 · Cited by 390
Koike, H., Iijima, M., & Chaki, S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.035 · Cited by 346
Research works printed but not linked: 27
- Andrade, 2017, Ketamine for depression, 4. In what dose, at what rate, by what route, for how long, and at what frequency?, The Journal of Clinical Psychiatry, 78, e852, 10.4088/JCP.17f11738 · DOI · Paper page
- Ates-Alagoz, 2013, NMDA receptor antagonists for treatment of depression, Pharmaceuticals, 6, 480, 10.3390/ph6040480 · DOI · Paper page
- Berman, 2000, Antidepressant effects of ketamine in depressed patients, Biological Psychiatry, 47, 351, 10.1016/S0006-3223(99)00230-9 · DOI · Paper page
- Carspecken, 2018, Ketamine anesthesia does not improve depression scores in electroconvulsive therapy: A randomized clinical trial, Journal of Neurosurgical Anesthesiology, 1
- Chang, 2016, Major depressive disorder induced by chronic ketamine abuse: A case report, The Primary Care Companion for CNS Disorders, 18
- Cruz, 2009, Toluene has antidepressant-like actions in two animal models used for the screening of antidepressant drugs, Psychopharmacology, 204, 279, 10.1007/s00213-009-1462-2 · DOI
- de Oliveira, 2009, Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 1003, 10.1016/j.pnpbp.2009.05.010 · DOI
- Fraga, 2013, Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration, Revista Brasileira de Psiquiatria, 35, 262, 10.1590/1516-4446-2012-0858 · DOI · Paper page
- Garcia, 2008, Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32, 140, 10.1016/j.pnpbp.2007.07.027 · DOI · Paper page
- Gibson, 2004, Mitochondrial Enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases, Journal of Bioenergetics and Biomembranes, 6
- Henley, 2016, Synaptic AMPA receptor composition in development, plasticity and disease, Nature Reviews Neuroscience, 17, 337, 10.1038/nrn.2016.37 · DOI · Paper page
- Iwata, 1997, Different effects of oxidative stress on activation of transcription factors in primary cultured rat neuronal and glial cells, Molecular Brain Research, 50, 213, 10.1016/S0169-328X(97)00190-3 · DOI
- Krystal, 1994, Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses, Archives of General Psychiatry, 51, 199, 10.1001/archpsyc.1994.03950030035004 · DOI · Paper page
- Kudoh, 2002, Small-dose ketamine improves the postoperative state of depressed patients, Anesthesia & Analgesia, 95, 114, 10.1097/00000539-200207000-00020 · DOI · Paper page
- Lara, 2013, Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression, The International Journal of Neuropsychopharmacology, 16, 2111, 10.1017/S1461145713000485 · DOI · Paper page
- Li, 2015, Drug pharmacokinetics determined by real-time analysis of mouse breath, Angewandte Chemie International Edition, 54, 7815, 10.1002/anie.201503312 · DOI
- Ma, 2013, Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice, PLoS ONE, 8, e56053, 10.1371/journal.pone.0056053 · DOI · Paper page
- Mao, 2012, Anti-depressant-like effect of peony: A mini-review, Pharmaceutical Biology, 50, 72, 10.3109/13880209.2011.602696 · DOI
- Noda, 2000, Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice imbalance of prefrontal serotonergic and dopaminergic functions, Neuropsychopharmacology, 23, 375, 10.1016/S0893-133X(00)00138-X · DOI
- Pitsikas, 2009, Pre-training administration of anesthetic ketamine differentially affects rats’ spatial and non-spatial recognition memory, Neuropharmacology, 57, 1, 10.1016/j.neuropharm.2009.03.015 · DOI
- Seillier, 2009, Evaluation of NMDA receptor models of schizophrenia: Divergences in the behavioral effects of sub-chronic PCP and MK-80, Behavioural Brain Research, 6
- Singh, 2016, Intravenous esketamine in adult treatment-resistant depression: A double-blind, double-randomization, placebo-controlled study, Biological Psychiatry, 80, 424, 10.1016/j.biopsych.2015.10.018 · DOI · Paper page
- Venâncio, 2015, Acute ketamine impairs mitochondrial function and promotes superoxide dismutase activity in the rat brain, Anesthesia & Analgesia, 120, 9, 10.1213/ANE.0000000000000539 · DOI
- Wang, 2011, A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats, Anesthesiology, 115, 812, 10.1097/ALN.0b013e31822f16ae · DOI · Paper page
- Zarate, 2015, Ketamine for depression: Evidence, challenges and promise, World Psychiatry, 14, 348, 10.1002/wps.20269 · DOI · Paper page
- Zarate, 2006, A Randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression, Archives of General Psychiatry, 63, 9, 10.1001/archpsyc.63.8.856 · DOI · Paper page
- Zou, 2006, CREB and NF-κB transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death, Cell Mol Neurobiol, 26, 383, 10.1007/s10571-006-9045-9 · DOI · Paper page
Cited by
Matveychuk, D., Thomas, R. K., Swainson, J., Khullar, A., MacKay, M.-A., Baker, G. B., & Dursun, S. M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320916657 · Cited by 209
Ribeiro, A. C. R., Jahr, F. M., Hawkins, E., Kronfol, M. M., Younis, R. M., McClay, J. L., & Deshpande, L. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119765 · Cited by 30
(2020) · Advances in Pharmacology · doi:10.1016/bs.apha.2020.04.003 · Cited by 18
Metadata
- Authors
- Wu, C., Wang, Y., He, Y., Wu, S., Xie, Z., Zhang, J., Shen, J., Wang, Z., & He, L.
- Venue
- Neurobiology of Learning and Memory
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 167
- Pages
- 107136
- ISSN
- 1074-7427 (ISSN-L)
- OpenAlex
- W2991906941
- Cited by
- 51
- References
- 18
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Chinese Academy of Sciences (XDA12040105)
- Science and Technology Commission of Shanghai Municipality (17431900500)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sub-anesthetic and anesthetic ketamine produce different long-lasting behavioral phenotypes (24 h post-treatment) via inducing different brain-derived neurotrophic factor (BDNF) expression level in the hippocampus. https://app.cochat.ai/papers/10.1016/j.nlm.2019.107136
- The paper
- Wu, C., Wang, Y., He, Y., Wu, S., Xie, Z., Zhang, J., Shen, J., Wang, Z., & He, L. (2020). Sub-anesthetic and anesthetic ketamine produce different long-lasting behavioral phenotypes (24 h post-treatment) via inducing different brain-derived neurotrophic factor (BDNF) expression level in the hippocampus. Neurobiology of Learning and Memory. https://doi.org/10.1016/j.nlm.2019.107136
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.